Citigroup’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,888
| Closed | -$1K | – | 5781 |
|
|
2022
Q2 | $1K | Buy |
+1,888
| New | +$1K | ﹤0.01% | 5343 |
|
|
2021
Q3 | – | Sell |
-300
| Closed | -$1K | – | 5658 |
|
|
2021
Q2 | $1K | Sell |
300
-1,086
| -78% | -$3.62K | ﹤0.01% | 5389 |
|
|
2021
Q1 | $10K | Sell |
1,386
-1,953
| -58% | -$14.1K | ﹤0.01% | 5000 |
|
|
2020
Q4 | $25K | Buy |
3,339
+2,454
| +277% | +$18.4K | ﹤0.01% | 4510 |
|
|
2020
Q3 | $8K | Sell |
885
-930
| -51% | -$8.41K | ﹤0.01% | 4464 |
|
|
2020
Q2 | $15K | Sell |
1,815
-330
| -15% | -$2.73K | ﹤0.01% | 4451 |
|
|
2020
Q1 | $11K | Buy |
2,145
+457
| +27% | +$2.34K | ﹤0.01% | 4610 |
|
|
2019
Q4 | $12K | Buy |
1,688
+532
| +46% | +$3.78K | ﹤0.01% | 4675 |
|
|
2019
Q3 | $12K | Sell |
1,156
-1,178
| -50% | -$12.2K | ﹤0.01% | 4507 |
|
|
2019
Q2 | $31K | Buy |
2,334
+245
| +12% | +$3.25K | ﹤0.01% | 4397 |
|
|
2019
Q1 | $21K | Buy |
2,089
+1,600
| +327% | +$16.1K | ﹤0.01% | 4506 |
|
|
2018
Q4 | $5K | Buy |
+489
| New | +$5K | ﹤0.01% | 4781 |
|